MedPage Today on MSN
Another B-cell drug for lupus hits the mark
Phase III results put obinutuzumab in line for approval ...
January is Mental Wellness Month! We asked Heather Rose Artushin, a licensed clinical social worker, to share information and insights into understanding and protecting your mental health when you ...
News-Medical.Net on MSN
NIH grant supports Oklahoma researcher investigating protein linked to lupus
For the millions of people living with lupus – a chronic autoimmune disease that can damage the kidneys, brain and other ...
Everyday Health on MSN
How I manage my lupus while also coping with rheumatoid arthritis
Shontia Matlock shares her experience managing lupus and rheumatoid arthritis. Discover how she navigates treatment, faces emotional challenges, and advocates for herself.
One of the most common viruses in the world could be the cause of lupus, an autoimmune disease with wide-ranging symptoms, according to a study published Wednesday. Until now, lupus was somewhat ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that a detailed analysis of the Phase III ALLEGORY trial of Gazyva® (obinutuzumab) in adults with systemic lupus ...
Novel allogeneic CAR-T therapy demonstrates durable remission and immune-reset mechanism in systemic lupus erythematosusBOSTON, March 02, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results